-
2
-
-
80051700067
-
Pancreatic cancer
-
Vincent A, Herman J, Schulick R, Hruban RH and Goggins M: Pancreatic cancer. Lancet 378:607-620, 2011.
-
(2011)
Lancet
, vol.378
, pp. 607-620
-
-
Vincent, A.1
Herman, J.2
Schulick, R.3
Hruban, R.H.4
Goggins, M.5
-
3
-
-
44449178868
-
Rho GTPases in cancer cell biology
-
Vega FM and Ridley AJ: Rho GTPases in cancer cell biology. FEBS Lett 582:2093-2101, 2008.
-
(2008)
FEBS Lett
, vol.582
, pp. 2093-2101
-
-
Vega, F.M.1
Ridley, A.J.2
-
4
-
-
84855894667
-
Rho GTPases and cancer cell transendothelial migration
-
Reymond N, Riou P and Ridley AJ: Rho GTPases and cancer cell transendothelial migration. Methods Mol Biol 827:123-142, 2012.
-
(2012)
Methods Mol Biol
, vol.827
, pp. 123-142
-
-
Reymond, N.1
Riou, P.2
Ridley, A.J.3
-
7
-
-
84878020578
-
Rictor regulates cell migration by suppressing RhoGDI2
-
Agarwal NK, Chen CH, Cho H, Boulbes DR, Spooner E and Sarbassov DD: Rictor regulates cell migration by suppressing RhoGDI2. Oncogene 32:2521-2526, 2013.
-
(2013)
Oncogene
, vol.32
, pp. 2521-2526
-
-
Agarwal, N.K.1
Chen, C.H.2
Cho, H.3
Boulbes, D.R.4
Spooner, E.5
Sarbassov, D.D.6
-
9
-
-
84902678752
-
Depletion of RhoGDI2 expression inhibits the ability of invasion and migration in pancreatic carcinoma
-
Yi B, Hu Y, Qin G, et al: Depletion of RhoGDI2 expression inhibits the ability of invasion and migration in pancreatic carcinoma. Int J Mol Med 34:205-212, 2014.
-
(2014)
Int J Mol Med
, vol.34
, pp. 205-212
-
-
Yi, B.1
Hu, Y.2
Qin, G.3
-
10
-
-
84856088337
-
EMT and dissemination precede pancreatic tumor formation
-
Rhim AD, Mirek ET, Aiello NM, et al: EMT and dissemination precede pancreatic tumor formation. Cell 148:349-361, 2012.
-
(2012)
Cell
, vol.148
, pp. 349-361
-
-
Rhim, A.D.1
Mirek, E.T.2
Aiello, N.M.3
-
11
-
-
84860229851
-
Epithelial-mesenchymal transition (EMT) protein expression in a cohort of stage II colorectal cancer patients with characterized tumor budding and mismatch repair protein status
-
Kevans D, Wang LM, Sheahan K, et al: Epithelial-mesenchymal transition (EMT) protein expression in a cohort of stage II colorectal cancer patients with characterized tumor budding and mismatch repair protein status. Int J Surg Pathol 19:751-760, 2011.
-
(2011)
Int J Surg Pathol
, vol.19
, pp. 751-760
-
-
Kevans, D.1
Wang, L.M.2
Sheahan, K.3
-
12
-
-
84877858964
-
Hypoxia stimulates the EMT of gastric cancer cells through autocrine TGFβ signaling
-
Matsuoka J, Yashiro M, Doi Y, et al: Hypoxia stimulates the EMT of gastric cancer cells through autocrine TGFβ signaling. PLoS One 8:e62310, 2013.
-
(2013)
PLoS One
, vol.8
, pp. e62310
-
-
Matsuoka, J.1
Yashiro, M.2
Doi, Y.3
-
13
-
-
84875470847
-
Breast cancer: Circulating and dynamic EMT
-
Burgess DJ: Breast cancer: Circulating and dynamic EMT. Nat Rev Cancer 13:148, 2013.
-
(2013)
Nat Rev Cancer
, vol.13
, pp. 148
-
-
Burgess, D.J.1
-
14
-
-
45549107919
-
Invasion and metastasis models for studying RhoGDI2 in bladder cancer
-
Nitz MD, Harding MA and Theodorescu D: Invasion and metastasis models for studying RhoGDI2 in bladder cancer. Methods Enzymol 439:219-233, 2008.
-
(2008)
Methods Enzymol
, vol.439
, pp. 219-233
-
-
Nitz, M.D.1
Harding, M.A.2
Theodorescu, D.3
-
15
-
-
84856670062
-
Overexpression of RhoGDI2 correlates with tumor progression and poor prognosis in colorectal carcinoma
-
Li X, Wang J, Zhang X, Zeng Y, Liang L and Ding Y: Overexpression of RhoGDI2 correlates with tumor progression and poor prognosis in colorectal carcinoma. Ann Surg Oncol 19:145-153, 2012.
-
(2012)
Ann Surg Oncol
, vol.19
, pp. 145-153
-
-
Li, X.1
Wang, J.2
Zhang, X.3
Zeng, Y.4
Liang, L.5
Ding, Y.6
-
16
-
-
0027237511
-
Ly-GDI, a GDP-dissociation inhibitor of the RhoA GTP-binding protein, is expressed preferentially in lymphocytes
-
Scherle P, Behrens T and Staudt LM: Ly-GDI, a GDP-dissociation inhibitor of the RhoA GTP-binding protein, is expressed preferentially in lymphocytes. Proc Natl Acad Sci USA 90:7568-7572, 1993.
-
(1993)
Proc Natl Acad Sci USA
, vol.90
, pp. 7568-7572
-
-
Scherle, P.1
Behrens, T.2
Staudt, L.M.3
-
17
-
-
77954356790
-
Expression profile of RhoGDI2 in lung cancers and role of RhoGDI2 in lung cancer metastasis
-
Niu H, Li H, Xu C and He P: Expression profile of RhoGDI2 in lung cancers and role of RhoGDI2 in lung cancer metastasis. Oncol Rep 24:465-471, 2010.
-
(2010)
Oncol Rep
, vol.24
, pp. 465-471
-
-
Niu, H.1
Li, H.2
Xu, C.3
He, P.4
-
18
-
-
84859571571
-
Proteomics-based strategy to delineate the molecular mechanisms of RhoGDI2-induced metastasis and drug resistance in gastric cancer
-
Cho HJ, Baek KE, Kim IK, et al: Proteomics-based strategy to delineate the molecular mechanisms of RhoGDI2-induced metastasis and drug resistance in gastric cancer. J Proteome Res 11:2355-2364, 2012.
-
(2012)
J Proteome Res
, vol.11
, pp. 2355-2364
-
-
Cho, H.J.1
Baek, K.E.2
Kim, I.K.3
-
19
-
-
2542606977
-
Reduced expression of metastasis suppressor RhoGDI2 is associated with decreased survival for patients with bladder cancer
-
Theodorescu D, Sapinoso LM, Conaway MR, Oxford G, Hampton GM and Frierson HF Jr: Reduced expression of metastasis suppressor RhoGDI2 is associated with decreased survival for patients with bladder cancer. Clin Cancer Res 10:3800-3806, 2004.
-
(2004)
Clin Cancer Res
, vol.10
, pp. 3800-3806
-
-
Theodorescu, D.1
Sapinoso, L.M.2
Conaway, M.R.3
Oxford, G.4
Hampton, G.M.5
Frierson, H.F.6
-
20
-
-
34848854515
-
Loss of expression of LyGDI (ARHGDIB), a rho GDP-dissociation inhibitor, in Hodgkin lymphoma
-
Ma L, Xu G, Sotnikova A, et al: Loss of expression of LyGDI (ARHGDIB), a rho GDP-dissociation inhibitor, in Hodgkin lymphoma. Br J Haematol 139:217-223, 2007.
-
(2007)
Br J Haematol
, vol.139
, pp. 217-223
-
-
Ma, L.1
Xu, G.2
Sotnikova, A.3
-
21
-
-
23944518413
-
RhoGDI: Multiple functions in the regulation of Rho family GTPase activities
-
Dovas A and Couchman JR: RhoGDI: multiple functions in the regulation of Rho family GTPase activities. Biochem J 390:1-9, 2005.
-
(2005)
Biochem J
, vol.390
, pp. 1-9
-
-
Dovas, A.1
Couchman, J.R.2
-
22
-
-
21744432683
-
GDIs: Central regulatory molecules in Rho GTPase activation
-
Der Mardirossian C and Bokoch GM: GDIs: central regulatory molecules in Rho GTPase activation. Trends Cell Biol 15:356-363, 2005.
-
(2005)
Trends Cell Biol
, vol.15
, pp. 356-363
-
-
Der Mardirossian, C.1
Bokoch, G.M.2
-
23
-
-
0026496258
-
A GDP dissociation inhibitor that serves as a GTPase inhibitor for the Ras-like protein CDC42Hs
-
Hart MJ, Maru Y, Leonard D, Witte ON, Evans T and Cerione RA: A GDP dissociation inhibitor that serves as a GTPase inhibitor for the Ras-like protein CDC42Hs. Science 258:812-815, 1992.
-
(1992)
Science
, vol.258
, pp. 812-815
-
-
Hart, M.J.1
Maru, Y.2
Leonard, D.3
Witte, O.N.4
Evans, T.5
Cerione, R.A.6
-
24
-
-
0027393663
-
GDP dissociation inhibitor prevents intrinsic and GTPase activating protein-stimulated GTP hydrolysis by the Rac GTP-binding protein
-
Chuang TH, Xu X, Knaus UG, Hart MJ and Bokoch GM: GDP dissociation inhibitor prevents intrinsic and GTPase activating protein-stimulated GTP hydrolysis by the Rac GTP-binding protein. J Biol Chem 268:775-778, 1993.
-
(1993)
J Biol Chem
, vol.268
, pp. 775-778
-
-
Chuang, T.H.1
Xu, X.2
Knaus, U.G.3
Hart, M.J.4
Bokoch, G.M.5
-
25
-
-
65349132693
-
EMT, the cytoskeleton, and cancer cell invasion
-
Yilmaz M and Christofori G: EMT, the cytoskeleton, and cancer cell invasion. Cancer Metastasis Rev 28:15-33, 2009.
-
(2009)
Cancer Metastasis Rev
, vol.28
, pp. 15-33
-
-
Yilmaz, M.1
Christofori, G.2
-
26
-
-
79960360062
-
E-Cadherin loss associated with EMT promotes radioresistance in human tumor cells
-
Theys J, Jutten B, Habets R, et al: E-Cadherin loss associated with EMT promotes radioresistance in human tumor cells. Radiother Oncol 99:392-397, 2011.
-
(2011)
Radiother Oncol
, vol.99
, pp. 392-397
-
-
Theys, J.1
Jutten, B.2
Habets, R.3
|